Glioblastoma multiforme, the brain cancer that killed Sen. Edward Kennedy, is aggressive and incurable. Researchers can now demonstrate delivery of a drug that turns off a critical gene in this complex cancer, increasing survival rates significantly in animals with the disease. The therapeutic, based on nanotechnology, is nimble enough to cross the blood-brain barrier and get to the brain tumor. Once there, it flips the switch of the oncogene to "off," silencing the gene.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/c...



Tendencias Científicas
La prevención del VIH no llega a las jóvenes sudafricanas

CIENCIA ON LINE